PMID: 4887043Apr 12, 1969Paper

Erythraemia in renal transplantation

British Medical Journal
J D Swales, D B Evans

Abstract

Seven cases of erythraemia following successful renal transplantation are described. This complication was not necessarily associated with clinical evidence of rejection of the transplant, and the prognosis so far as rejection was concerned was excellent. Four patients, however, developed thromboembolic pulmonary complications, and two other patients had thrombotic episodes. Hence it is suggested that treatment either by anticoagulation or by venesection is indicated.

References

Dec 3, 1966·British Medical Journal·R Y CalneJ D Swales
Mar 29, 1968·Annals of the New York Academy of Sciences·G C Hoffman
Oct 7, 1965·The New England Journal of Medicine·B A NiesS L Schrier
May 1, 1967·The American Journal of the Medical Sciences·J D Swales
Dec 1, 1966·The American Journal of Cardiology·R C TaraziI H Page
Jan 7, 1967·British Medical Journal·P HudgsonW K Yeates
Aug 1, 1957·Clinica Chimica Acta; International Journal of Clinical Chemistry·J P NICHOLSON, J F ZILVA
Mar 22, 1965·JAMA : the Journal of the American Medical Association·S L KOUNTZR COHN

❮ Previous
Next ❯

Citations

Dec 1, 1990·Transplant International : Official Journal of the European Society for Organ Transplantation·M S IslamJ Cledes
Jan 22, 1991·Klinische Wochenschrift·M Wolff, W Jelkmann
Jul 30, 1988·Lancet
Jun 1, 1974·British Journal of Urology·J R Salaman, K Mahmood
Jul 1, 1972·Postgraduate Medical Journal·G A ColesS McVeigh
Jan 1, 2004·American Journal of Respiratory and Critical Care Medicine·Jo HasegawaStefan Uhlig
Jul 1, 1982·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D FreiP Gorman
Feb 5, 2009·Clinical Transplantation·Bryce A Kiberd
Dec 1, 1991·Blood Reviews·T C Pearson
Sep 1, 1987·Baillière's Clinical Haematology·T C Pearson
Aug 1, 1975·Urology·R NellansD C Martin
May 1, 1985·Artificial Organs·S Lamperi, S Carozzi
Jul 20, 1989·The New England Journal of Medicine·C H SunD B Lee
Jan 1, 1971·Journal of Surgical Oncology·M J VarkarakisG P Murphy
Dec 1, 1991·Kidney International·W Y QunibiS Taher
May 1, 1983·Kidney International·C G WickreW M Bennett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.